Wikidata

(Q63574624)

English

Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

clinical trial

In more languages

Statements

title
Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma (English)
0 references
country
Australia
0 references
Brazil
0 references
Germany
0 references
Hungary
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
Turkey
0 references
Ukraine
0 references
start time
15 August 2014
0 references
end time
11 January 2016
0 references
number of participants
499
0 references
research intervention
(RS)-cyclophosphamide
0 references
dexamethasone acetate
0 references
bortezomib
0 references
daratumumab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63574624&oldid=2035755902"